Intco Medical Technology Co., Ltd. (300677.SZ)
- Previous Close
22.99 - Open
22.84 - Bid 22.70 x --
- Ask 22.71 x --
- Day's Range
22.63 - 23.03 - 52 Week Range
19.78 - 33.61 - Volume
5,412,459 - Avg. Volume
9,283,838 - Market Cap (intraday)
14.662B - Beta (5Y Monthly) 1.45
- PE Ratio (TTM)
9.26 - EPS (TTM)
2.45 - Earnings Date --
- Forward Dividend & Yield 0.13 (0.57%)
- Ex-Dividend Date Oct 31, 2024
- 1y Target Est
38.00
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, health care equipment, and physiotherapy care products that are used in medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers gloves; face masks and shields; ECG electrode comprising monitoring and diagnostic ECG, stress test and holter, pre-wired neonatal, tens, and off-set ECG electrodes; apparels, such as isolation gowns; hand sanitizer gel and spray; grounding pads; electrosurgical pencil; and ESU cables and tip cleaner. It also provides wheelchairs, scooters, and other rehabilitation and medical equipment; hot and cold products, emergency treatment products, and mother and baby products; and home care and cold chain products. The company was formerly known as Intco Medical Technology Co., Ltd. and changed its name to Intco Medical Technology Co., Ltd. in January 2020. Intco Medical Technology Co., Ltd. was founded in 2009 and is headquartered in Zibo, China.
www.intcomedical.com.cn10,982
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 300677.SZ
View MorePerformance Overview: 300677.SZ
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300677.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300677.SZ
View MoreValuation Measures
Market Cap
14.86B
Enterprise Value
--
Trailing P/E
9.38
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.51
Price/Book (mrq)
0.84
Enterprise Value/Revenue
0.96
Enterprise Value/EBITDA
4.60
Financial Highlights
Profitability and Income Statement
Profit Margin
16.10%
Return on Assets (ttm)
1.90%
Return on Equity (ttm)
9.32%
Revenue (ttm)
9.81B
Net Income Avi to Common (ttm)
1.58B
Diluted EPS (ttm)
2.45
Balance Sheet and Cash Flow
Total Cash (mrq)
20.99B
Total Debt/Equity (mrq)
86.46%
Levered Free Cash Flow (ttm)
-1.28B